nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Methotrexate—ankylosing spondylitis	0.0934	0.103	CbGbCtD
Amprenavir—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0864	0.0949	CbGbCtD
Amprenavir—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0742	0.0815	CbGbCtD
Amprenavir—CYP2C19—Prednisone—ankylosing spondylitis	0.0557	0.0612	CbGbCtD
Amprenavir—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0547	0.0602	CbGbCtD
Amprenavir—ABCB1—Betamethasone—ankylosing spondylitis	0.0482	0.053	CbGbCtD
Amprenavir—ABCB1—Prednisolone—ankylosing spondylitis	0.0476	0.0523	CbGbCtD
Amprenavir—ABCB1—Prednisone—ankylosing spondylitis	0.0449	0.0494	CbGbCtD
Amprenavir—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0444	0.0489	CbGbCtD
Amprenavir—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0431	0.0474	CbGbCtD
Amprenavir—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0414	0.0456	CbGbCtD
Amprenavir—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0348	0.0382	CbGbCtD
Amprenavir—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0337	0.037	CbGbCtD
Amprenavir—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0289	0.0318	CbGbCtD
Amprenavir—CYP3A4—Betamethasone—ankylosing spondylitis	0.0289	0.0318	CbGbCtD
Amprenavir—CYP3A4—Prednisolone—ankylosing spondylitis	0.0285	0.0313	CbGbCtD
Amprenavir—ABCB1—Dexamethasone—ankylosing spondylitis	0.0281	0.0308	CbGbCtD
Amprenavir—CYP3A4—Prednisone—ankylosing spondylitis	0.0269	0.0296	CbGbCtD
Amprenavir—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0264	0.0291	CbGbCtD
Amprenavir—ABCB1—Methotrexate—ankylosing spondylitis	0.0225	0.0248	CbGbCtD
Amprenavir—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0168	0.0185	CbGbCtD
Amprenavir—Affective disorder—Methylprednisolone—ankylosing spondylitis	0.00851	0.0942	CcSEcCtD
Amprenavir—Buffalo hump—Prednisone—ankylosing spondylitis	0.00421	0.0466	CcSEcCtD
Amprenavir—Lipohypertrophy—Prednisone—ankylosing spondylitis	0.00387	0.0428	CcSEcCtD
Amprenavir—Opportunistic infection—Methylprednisolone—ankylosing spondylitis	0.00265	0.0293	CcSEcCtD
Amprenavir—Opportunistic infection—Dexamethasone—ankylosing spondylitis	0.00241	0.0267	CcSEcCtD
Amprenavir—Opportunistic infection—Betamethasone—ankylosing spondylitis	0.00241	0.0267	CcSEcCtD
Amprenavir—Opportunistic infection—Prednisone—ankylosing spondylitis	0.0021	0.0232	CcSEcCtD
Amprenavir—Opportunistic infection—Methotrexate—ankylosing spondylitis	0.00175	0.0194	CcSEcCtD
Amprenavir—Hypertriglyceridaemia—Prednisone—ankylosing spondylitis	0.00147	0.0163	CcSEcCtD
Amprenavir—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00129	0.0143	CcSEcCtD
Amprenavir—Inflammation—Methylprednisolone—ankylosing spondylitis	0.0011	0.0122	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000971	0.0107	CcSEcCtD
Amprenavir—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.000893	0.00989	CcSEcCtD
Amprenavir—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000893	0.00988	CcSEcCtD
Amprenavir—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.000891	0.00985	CcSEcCtD
Amprenavir—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.00081	0.00896	CcSEcCtD
Amprenavir—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.00081	0.00896	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.000777	0.00859	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—ankylosing spondylitis	0.000728	0.00806	CcSEcCtD
Amprenavir—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000705	0.0078	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000683	0.00756	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000641	0.0071	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000638	0.00706	CcSEcCtD
Amprenavir—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00059	0.00653	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000589	0.00652	CcSEcCtD
Amprenavir—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000588	0.00651	CcSEcCtD
Amprenavir—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000586	0.00649	CcSEcCtD
Amprenavir—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000585	0.00648	CcSEcCtD
Amprenavir—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.000549	0.00608	CcSEcCtD
Amprenavir—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.000549	0.00608	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000541	0.00599	CcSEcCtD
Amprenavir—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000535	0.00592	CcSEcCtD
Amprenavir—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000535	0.00592	CcSEcCtD
Amprenavir—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000532	0.00589	CcSEcCtD
Amprenavir—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000532	0.00589	CcSEcCtD
Amprenavir—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000527	0.00583	CcSEcCtD
Amprenavir—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000497	0.0055	CcSEcCtD
Amprenavir—Neutropenia—Prednisone—ankylosing spondylitis	0.000496	0.00549	CcSEcCtD
Amprenavir—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000478	0.00529	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000473	0.00524	CcSEcCtD
Amprenavir—Depression—Prednisone—ankylosing spondylitis	0.000471	0.00522	CcSEcCtD
Amprenavir—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000469	0.0052	CcSEcCtD
Amprenavir—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000466	0.00516	CcSEcCtD
Amprenavir—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000466	0.00516	CcSEcCtD
Amprenavir—Angioedema—Prednisolone—ankylosing spondylitis	0.000465	0.00514	CcSEcCtD
Amprenavir—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000463	0.00513	CcSEcCtD
Amprenavir—Discomfort—Prednisolone—ankylosing spondylitis	0.000428	0.00473	CcSEcCtD
Amprenavir—Angioedema—Triamcinolone—ankylosing spondylitis	0.000427	0.00473	CcSEcCtD
Amprenavir—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000426	0.00472	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000425	0.0047	CcSEcCtD
Amprenavir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000417	0.00461	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—ankylosing spondylitis	0.000414	0.00459	CcSEcCtD
Amprenavir—Myalgia—Triamcinolone—ankylosing spondylitis	0.000398	0.0044	CcSEcCtD
Amprenavir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000397	0.00439	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000394	0.00436	CcSEcCtD
Amprenavir—Depression—Methotrexate—ankylosing spondylitis	0.000394	0.00436	CcSEcCtD
Amprenavir—Discomfort—Triamcinolone—ankylosing spondylitis	0.000393	0.00435	CcSEcCtD
Amprenavir—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000392	0.00434	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000392	0.00433	CcSEcCtD
Amprenavir—Angioedema—Betamethasone—ankylosing spondylitis	0.000388	0.00429	CcSEcCtD
Amprenavir—Angioedema—Dexamethasone—ankylosing spondylitis	0.000388	0.00429	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000374	0.00413	CcSEcCtD
Amprenavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000373	0.00413	CcSEcCtD
Amprenavir—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000373	0.00412	CcSEcCtD
Amprenavir—Mental disorder—Prednisone—ankylosing spondylitis	0.000372	0.00411	CcSEcCtD
Amprenavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00037	0.00409	CcSEcCtD
Amprenavir—Malnutrition—Prednisone—ankylosing spondylitis	0.000369	0.00409	CcSEcCtD
Amprenavir—Myalgia—Betamethasone—ankylosing spondylitis	0.000361	0.004	CcSEcCtD
Amprenavir—Myalgia—Dexamethasone—ankylosing spondylitis	0.000361	0.004	CcSEcCtD
Amprenavir—Discomfort—Betamethasone—ankylosing spondylitis	0.000357	0.00395	CcSEcCtD
Amprenavir—Discomfort—Dexamethasone—ankylosing spondylitis	0.000357	0.00395	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000348	0.00385	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000347	0.00384	CcSEcCtD
Amprenavir—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000343	0.00379	CcSEcCtD
Amprenavir—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000342	0.00378	CcSEcCtD
Amprenavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00034	0.00376	CcSEcCtD
Amprenavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00034	0.00376	CcSEcCtD
Amprenavir—Angioedema—Prednisone—ankylosing spondylitis	0.000338	0.00374	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000335	0.00371	CcSEcCtD
Amprenavir—Anorexia—Dexamethasone—ankylosing spondylitis	0.00033	0.00365	CcSEcCtD
Amprenavir—Anorexia—Betamethasone—ankylosing spondylitis	0.00033	0.00365	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000329	0.00364	CcSEcCtD
Amprenavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.000329	0.00364	CcSEcCtD
Amprenavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000328	0.00363	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000315	0.00349	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000315	0.00349	CcSEcCtD
Amprenavir—Myalgia—Prednisone—ankylosing spondylitis	0.000315	0.00348	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000312	0.00346	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000311	0.00345	CcSEcCtD
Amprenavir—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000311	0.00344	CcSEcCtD
Amprenavir—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000311	0.00344	CcSEcCtD
Amprenavir—Discomfort—Prednisone—ankylosing spondylitis	0.000311	0.00344	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—ankylosing spondylitis	0.000311	0.00344	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.000309	0.00342	CcSEcCtD
Amprenavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000301	0.00333	CcSEcCtD
Amprenavir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000301	0.00333	CcSEcCtD
Amprenavir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000301	0.00333	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000299	0.00331	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000299	0.00331	CcSEcCtD
Amprenavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.000298	0.0033	CcSEcCtD
Amprenavir—Fatigue—Betamethasone—ankylosing spondylitis	0.000298	0.0033	CcSEcCtD
Amprenavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000296	0.00327	CcSEcCtD
Amprenavir—Skin disorder—Prednisone—ankylosing spondylitis	0.000293	0.00324	CcSEcCtD
Amprenavir—Anorexia—Prednisone—ankylosing spondylitis	0.000287	0.00318	CcSEcCtD
Amprenavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000283	0.00313	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000283	0.00313	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000275	0.00304	CcSEcCtD
Amprenavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000274	0.00303	CcSEcCtD
Amprenavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000274	0.00303	CcSEcCtD
Amprenavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000274	0.00303	CcSEcCtD
Amprenavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000273	0.00302	CcSEcCtD
Amprenavir—Paraesthesia—Prednisone—ankylosing spondylitis	0.000271	0.003	CcSEcCtD
Amprenavir—Pruritus—Triamcinolone—ankylosing spondylitis	0.00027	0.00299	CcSEcCtD
Amprenavir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000269	0.00298	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—ankylosing spondylitis	0.000263	0.00291	CcSEcCtD
Amprenavir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000262	0.0029	CcSEcCtD
Amprenavir—Rash—Prednisolone—ankylosing spondylitis	0.000262	0.00289	CcSEcCtD
Amprenavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000261	0.00289	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000261	0.00289	CcSEcCtD
Amprenavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00026	0.00288	CcSEcCtD
Amprenavir—Fatigue—Prednisone—ankylosing spondylitis	0.00026	0.00288	CcSEcCtD
Amprenavir—Headache—Prednisolone—ankylosing spondylitis	0.00026	0.00288	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—ankylosing spondylitis	0.00026	0.00287	CcSEcCtD
Amprenavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000248	0.00275	CcSEcCtD
Amprenavir—Asthenia—Betamethasone—ankylosing spondylitis	0.000248	0.00275	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000247	0.00273	CcSEcCtD
Amprenavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000247	0.00273	CcSEcCtD
Amprenavir—Nausea—Prednisolone—ankylosing spondylitis	0.000246	0.00273	CcSEcCtD
Amprenavir—Pruritus—Betamethasone—ankylosing spondylitis	0.000245	0.00271	CcSEcCtD
Amprenavir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000245	0.00271	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00271	CcSEcCtD
Amprenavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000243	0.00268	CcSEcCtD
Amprenavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000242	0.00268	CcSEcCtD
Amprenavir—Rash—Triamcinolone—ankylosing spondylitis	0.000241	0.00266	CcSEcCtD
Amprenavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00024	0.00266	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—ankylosing spondylitis	0.00024	0.00266	CcSEcCtD
Amprenavir—Rash—Methylprednisolone—ankylosing spondylitis	0.00024	0.00266	CcSEcCtD
Amprenavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00024	0.00265	CcSEcCtD
Amprenavir—Headache—Triamcinolone—ankylosing spondylitis	0.000239	0.00265	CcSEcCtD
Amprenavir—Headache—Methylprednisolone—ankylosing spondylitis	0.000239	0.00264	CcSEcCtD
Amprenavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000238	0.00264	CcSEcCtD
Amprenavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000237	0.00262	CcSEcCtD
Amprenavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000237	0.00262	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00023	0.00254	CcSEcCtD
Amprenavir—Nausea—Triamcinolone—ankylosing spondylitis	0.000227	0.00251	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000226	0.0025	CcSEcCtD
Amprenavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000226	0.0025	CcSEcCtD
Amprenavir—Vomiting—Betamethasone—ankylosing spondylitis	0.00022	0.00244	CcSEcCtD
Amprenavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00022	0.00244	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000219	0.00242	CcSEcCtD
Amprenavir—Rash—Betamethasone—ankylosing spondylitis	0.000218	0.00242	CcSEcCtD
Amprenavir—Rash—Dexamethasone—ankylosing spondylitis	0.000218	0.00242	CcSEcCtD
Amprenavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000218	0.00241	CcSEcCtD
Amprenavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000218	0.00241	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000218	0.00241	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—ankylosing spondylitis	0.000217	0.0024	CcSEcCtD
Amprenavir—Headache—Betamethasone—ankylosing spondylitis	0.000217	0.0024	CcSEcCtD
Amprenavir—Headache—Dexamethasone—ankylosing spondylitis	0.000217	0.0024	CcSEcCtD
Amprenavir—Asthenia—Prednisone—ankylosing spondylitis	0.000216	0.00239	CcSEcCtD
Amprenavir—Pruritus—Prednisone—ankylosing spondylitis	0.000213	0.00236	CcSEcCtD
Amprenavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000206	0.00228	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000206	0.00228	CcSEcCtD
Amprenavir—Nausea—Dexamethasone—ankylosing spondylitis	0.000206	0.00228	CcSEcCtD
Amprenavir—Nausea—Betamethasone—ankylosing spondylitis	0.000206	0.00228	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000199	0.0022	CcSEcCtD
Amprenavir—Vomiting—Prednisone—ankylosing spondylitis	0.000192	0.00212	CcSEcCtD
Amprenavir—Rash—Prednisone—ankylosing spondylitis	0.00019	0.0021	CcSEcCtD
Amprenavir—Dermatitis—Prednisone—ankylosing spondylitis	0.00019	0.0021	CcSEcCtD
Amprenavir—Headache—Prednisone—ankylosing spondylitis	0.000189	0.00209	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—ankylosing spondylitis	0.000181	0.002	CcSEcCtD
Amprenavir—Nausea—Prednisone—ankylosing spondylitis	0.000179	0.00198	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—ankylosing spondylitis	0.000178	0.00197	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000172	0.00191	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—ankylosing spondylitis	0.00016	0.00177	CcSEcCtD
Amprenavir—Rash—Methotrexate—ankylosing spondylitis	0.000159	0.00176	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000159	0.00176	CcSEcCtD
Amprenavir—Headache—Methotrexate—ankylosing spondylitis	0.000158	0.00175	CcSEcCtD
Amprenavir—Nausea—Methotrexate—ankylosing spondylitis	0.00015	0.00166	CcSEcCtD
